GLSI

Greenwich LifeSciences, Inc.

11.43 USD

Last updated Dec 6, 04:14 UTC

Yesterday HIGH

$11.65

Yesterday LOW

$11.25

52w HIGH

$21.5

52w LOW

$7.58

EPS

-0.19

PE

-60.16

Next Earnings

Apr 1, 2024

Overview News Insider Transactions Government Trades

Greenwich LifeSciences, Inc. stock is up 9.59% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 December’s closed higher than November.

Greenwich LifeSciences focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

greenwichlifesciences.com

Charles Gross

Thu Apr 13, 2023

Greenwich Lifesciences Confirms FDA Reviewed Co's Phase IIB Clinical Data Before The Commencement Of The Flamingo-01 Clinical Trial; Confirmed Company Is Planning An Expansion Of The Flamingo-01 Clinical Trial Into Europe

-8-K
Benzinga Newsdesk

Mon Apr 10, 2023

HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Lowers Price Target to $38

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price target from $78 to $38.
Lisa Levin

Wed Jan 11, 2023

$4.7M Bet On Tilly's? Check Out These 3 Stocks Insiders Are Buying

Although US stocks closed higher on Tuesday, there were a few notable insider trades.
Lisa Levin

Fri Nov 25, 2022

Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday

Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.
Chris Katje

Mon Oct 24, 2022

Bitcoin Holder MicroStrategy And 4 More Short Squeeze Stocks That Could Soar This Week

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move.
Chris Katje

Mon Oct 17, 2022

Virgin Orbit And 4 More Short Squeeze Stocks That Could Soar This Week — Including A Stock Moving Up 968 Positions

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the Fintel short squeeze leaderboard.
Chris Katje

Mon Oct 10, 2022

TOP Ships, Weber And 3 More Short Squeeze Stocks That Could Soar This Week

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the Fintel short squeeze leaderboard.
Chris Katje

Mon Oct 3, 2022

Grenwich LilfeSciences, Blue Apron And 3 More Short Squeeze Candidates That May Soar

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week of Oct. 3 based on the Fintel short squeeze leaderboard.
Chris Katje

Mon Sep 19, 2022

5 Short Squeeze Stocks That Could Soar: NeruoBo Pharmaceuticals, FaZe Holdings And More

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week of Sept. 19, according to Fintel Data:
Chris Katje

Mon Sep 12, 2022

10 Short Squeeze Candidates That May Soar: Athersys, TDH Holdings, FaZe Holdings, Weber And More

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week of Sept. 12, according to Fintel Data:

Patel Snehal, Director

Fri Nov 10, 2023

GLSI Recent Insider Trades and Stock Chart

5,000 shares bought
Patel Snehal, Director

Fri Nov 3, 2023

GLSI Recent Insider Trades and Stock Chart

3,500 shares bought